Clinical trials / NCT06081894
NCT06081894Phase 3Active not recruiting

A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

Study sponsor: Cytokinetics

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2026-08-31Actual
Enrollment · participants500Estimated
Source updated2026-09-22Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 2 fields changed

Completion date type changed

− Before

Estimated

+ After

Actual

Primary completion date changed

− Before

Aug 2026

+ After

31 Aug 2026

Check registry source

· 1 field changed

Primary completion date changed

− Before

Jun 2026

+ After

Aug 2026

Check registry source

· 1 field changed

Recruitment status changed

− Before

Recruiting

+ After

Active not recruiting

Check registry source